Phototherapy Equipment Market Size, Share, and Growth Analysis 2025-2033

<h1>Phototherapy Equipment Market Size, Share, and Growth Analysis 2025-2033</h1> Market Overview: The phototherapy equipment market is experiencing rapid growth, driven by surging prevalence of neonatal jaundice and preterm births, rising incidence of chronic dermatological conditions, and technological transition to led-based systems. According to IMARC Group’s latest research publication, “Phototherapy Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033”, the global <a href="https://www.imarcgroup.com/phototherapy-equipment-market">phototherapy equipment market</a> size reached USD 945.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,373.4 Million by 2033, exhibiting a growth rate (CAGR) of 4.02% during 2025-2033. This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis. Download a sample PDF of this report: <a href="https://www.imarcgroup.com/phototherapy-equipment-market/requestsample">https://www.imarcgroup.com/phototherapy-equipment-market/requestsample</a> Our report includes: <ul> <li>Market Dynamics</li> <li>Market Trends and Market Outlook</li> <li>Competitive Analysis</li> <li>Industry Segmentation</li> <li>Strategic Recommendations</li> </ul> Growth Factors in the Phototherapy Equipment Market <ul> <li data-path-to-node="1">Surging Prevalence of Neonatal Jaundice and Preterm Births</li> </ul> The increasing global incidence of neonatal jaundice remains a primary driver for the phototherapy equipment market. Clinical data indicates that hyperbilirubinemia affects nearly 60% of full-term newborns and 80% of preterm infants within the first week of life. In the United Kingdom, approximately 5% to 10% of all newborns require phototherapy intervention to prevent neurological complications. This demand is particularly acute in the Asia-Pacific region, which accounts for nearly 80% of global preterm births. Healthcare facilities are responding by expanding their Neonatal Intensive Care Units (NICUs), with India’s Ministry of Health reporting a 12% annual expansion in neonatal healthcare infrastructure. Consequently, hospitals are aggressively procuring high-intensity light systems to manage rising patient volumes. The consistent requirement for these life-saving interventions ensures a stable and expanding market for specialized neonatal phototherapy devices across both developed and emerging economies. <ul> <li data-path-to-node="3">Rising Incidence of Chronic Dermatological Conditions</li> </ul> The widespread occurrence of chronic skin diseases, including psoriasis, vitiligo, and atopic dermatitis, is significantly propelling the demand for phototherapy equipment. Global health statistics reveal that over 125 million people suffer from psoriasis, while atopic dermatitis affects approximately 18 million individuals in the United States alone. Phototherapy is increasingly favored as a non-invasive, drug-free alternative to systemic medications, which often carry a higher risk of side effects. In the United States, outpatient dermatology clinics reported a 30% surge in the adoption of portable phototherapy units in early 2025. This shift is driven by the clinical efficacy of narrowband ultraviolet B (NB-UVB) light in reducing inflammation and skin lesions. As urbanization and environmental factors contribute to the rising prevalence of these conditions, both patients and practitioners are prioritizing phototherapy systems that offer targeted treatment with minimal secondary impact on healthy tissue. <ul> <li data-path-to-node="5">Technological Transition to LED-Based Systems</li> </ul> A significant shift from traditional fluorescent lamps to advanced Light Emitting Diode (LED) technology is revolutionizing the phototherapy equipment landscape. LED-based systems now command a majority share of the market, exceeding 59% of global utilization. These devices are preferred for their superior energy efficiency, longer operational lifespans of up to 3,000 hours, and reduced heat emission, which enhances safety for sensitive patients like neonates. In 2024, the industry saw a 25% increase in LED device shipments compared to the previous year. Major players like Philips and GE HealthCare are heavily investing in product innovation to develop LED units with precise wavelength control, typically ranging from 400 to 550 nm. This technical evolution not only lowers operational costs for healthcare providers by reducing maintenance needs but also improves clinical outcomes through more uniform and intensive light distribution, making it a critical catalyst for industry-wide modernization. Key Trends in the Phototherapy Equipment Market <ul> <li data-path-to-node="9">Integration of Smart Connectivity and Remote Monitoring</li> </ul> The phototherapy equipment industry is witnessing a rapid integration of Internet of Things (IoT) capabilities and digital monitoring features. Modern devices are now frequently equipped with smart sensors that allow healthcare professionals to track treatment progress, adjust light intensity, and monitor dosage in real-time through mobile applications. This trend is particularly transformative for home-based care, where integrated dosage tracking ensures patients adhere to prescribed protocols. For instance, new systems can sync data directly with Electronic Health Records (EHRs), providing a holistic view of patient recovery. This connectivity addresses long-standing concerns regarding treatment compliance and safety, as practitioners can provide immediate feedback or intervene if a session deviates from the medical plan. The move toward "connected health" is streamlining the transition from hospital-grade supervision to effective, data-driven home therapy, enhancing the overall efficiency of dermatological and neonatal care. <ul> <li data-path-to-node="11">Proliferation of Portable and Home-Use Devices</li> </ul> There is a notable shift toward decentralized healthcare, characterized by the rising popularity of portable and handheld phototherapy equipment. Patients suffering from chronic conditions like vitiligo or eczema increasingly prefer at-home gadgets over frequent, time-consuming hospital visits. This trend is supported by the development of compact, user-friendly models that offer the same clinical precision as larger clinical units. In North America, the mobile phototherapy segment has seen substantial growth as insurance providers and patients recognize the cost-effectiveness of home management. For neonatal care, innovations such as fiber-optic blankets allow for "bili-blanket" therapy at home, enabling continuous treatment while facilitating parent-infant bonding. This trend toward miniaturization not only improves patient quality of life by providing greater flexibility but also reduces the burden on overstretched hospital facilities by allowing low-risk cases to be managed effectively in a domestic environment. <ul> <li data-path-to-node="13">Expansion of Wearable and Multi-Therapeutic Light Systems</li> </ul> Emerging wearable phototherapy technologies are redefining patient comfort and treatment versatility. Innovations such as LED-integrated textiles and face-fit masks are gaining traction for both medical and aesthetic applications. In early 2025, several tech brands launched FDA Class II-certified LED masks featuring multi-wavelength settings for acne treatment and skin rejuvenation. Beyond traditional dermatology, the market is seeing the rise of multi-therapeutic devices that combine light therapy with other modalities. For example, the recently unveiled TheraLight 360i integrates photobiomodulation with pulsed electromagnetic field therapy. These wearable and hybrid systems represent a move toward personalized and lifestyle-integrated medicine. By conforming to anatomical structures and offering uniform light distribution, these next-generation prototypes overcome the limitations of bulky, stationary equipment, making therapeutic light more accessible for diverse uses, ranging from neonatal jaundice management to sports medicine and anti-aging treatments. Leading Companies Operating in the Global Phototherapy Equipment Industry: <ul> <li>Atom Medical Corporation</li> <li>AVI Healthcare Private Limited</li> <li>General Electric Company</li> <li>Herbert Waldmann GmbH & Co. KG</li> <li>Ibis Medical Equipment & Systems Pvt Ltd</li> <li>Koninklijke Philips N.V.</li> <li>Narang Medical Limited</li> <li>National Biological Corporation</li> <li>Natus Medical Incorporated</li> <li>Nice Neotech Medical Systems Pvt. Ltd.</li> <li>Phoenix Medical Systems Pvt. Ltd.</li> <li>Solarc Systems Inc.</li> </ul> Phototherapy Equipment Market Report Segmentation: By Type: <ul> <li>Conventional Phototherapy Equipment <ul> <li>Conventional Phototherapy Equipment with Fluorescent Lamps</li> <li>Conventional Phototherapy Equipment with Compact Fluorescent Lamps</li> </ul> </li> <li>LED Phototherapy Equipment</li> <li>Fiberoptic Phototherapy Equipment</li> </ul> Conventional phototherapy equipment accounts for the majority of shares due to established clinical efficacy, widespread acceptance among healthcare providers, and cost-effectiveness. By Application: <ul> <li>Skin Disease Treatment <ul> <li>Psoriasis</li> <li>Vitiligo</li> <li>Eczema</li> <li>Others</li> </ul> </li> <li>Neonatal Jaundice Management</li> </ul> Skin disease treatment dominates the market owing to rising prevalence of dermatological conditions and proven effectiveness of phototherapy for inflammatory skin disorders. By End User: <ul> <li>Hospitals and Clinics</li> <li>Home Users</li> </ul> Hospitals and clinics account for the largest market share due to availability of specialized dermatology departments and requirement for supervised treatment protocols. Regional Insights: <ul> <li>North America (United States, Canada)</li> <li>Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)</li> <li>Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)</li> <li>Latin America (Brazil, Mexico, Others)</li> <li>Middle East and Africa</li> </ul> North America enjoys the leading position owing to advanced healthcare infrastructure, high prevalence of skin disorders, and strong awareness about phototherapy benefits. Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations. About Us: IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research. Contact Us: IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: sales@imarcgroup.com Tel No:(D) +91 120 433 0800 United States: +1-201971-6302